WASHINGTON — The Antiviral Drugs Advisory Committee of the Food and Drug Administration recommended the agency approve for preventative use Gilead’s AIDS treatment drug Truvada, according to MSNBC.
Testing has shown promise with high-risk patients in preventing HIV infection when taking the drug daily. Though concerns have been raised over the drug’s cost ($1,200 per month), the possibility for creating drug-resistant strains of the virus and side effects like nausea, HIV prevention specialists welcome the decision as part of a comprehensive toolkit to reducing new infections.
“Existing interventions have not reduced the number of new infections annually and new measures are needed,” Dr. John Mellors, chief of the infectious diseases division at the University of Pittsburgh, told MSNBC.
- Whoopi Goldberg and Rosie O’Donnell will guest star in gay miniseries ‘When We Rise’ by Mariah Cooper | posted on April 28, 2016
- What caused lesbian extinction? by Kate Clinton | posted on April 28, 2016
- Blade to escort Leakes, Harris-Perry to White House dinner by Staff reports | posted on April 27, 2016
- Md. schools join forces for gay prom by Mariah Cooper | posted on April 28, 2016
- Mayor’s aide to receive Black Pride award by Steve Charing | posted on September 9, 2014